Management of Male Breast Cancer

Publication Date: February 14, 2020

Key Points

Key Points

Male breast cancer is a rare disease representing less than 1% of all breast carcinomas diagnosed in the United States each year.

In 2019, an estimated 2,670 new cases of breast cancer will be diagnosed among men in the United States, and about 500 men will die from breast cancer.

The lifetime risk of breast cancer is about 1:1000 for a man, whereas it is approximately 1:8 for a woman.

There are substantial knowledge gaps concerning the optimal management of breast cancer in men.

To date, approaches to treating men with breast cancer have been extrapolated largely from research conducted in women with breast cancer.

Treatment

Treatment

...e receptor-positive breast cancer who are candida...


Men with hormone receptor-positive...


...re treated with adjuvant endocrine therapy...


...who have completed five years of t...


...with early-stage breast cancer should not...


...vanced or metastatic, hormone receptor-positive,...


...o develop recurrent metastatic, hormone re...


Endocrine therapy for men with advanced or...


...erapy guided by HER2, PDL-1, PIK3C...


...ent of endocrine therapy toxicity is similar...


...rogen supplementation should not be used by...


...s should counsel patients about the symptoms of re...


...psilateral annual mammogram should be offered...


...l annual mammogram may be offered to men with...


...MRI is not recommended routinely in men...


...atients with breast cancer should b...


...t Recommendations That Did Not Reach the...